Safety and efficacy of total dose iron dextran administration in patients on home renal replacement therapies

Peritoneal Dialysis International

Volumn 18, Issue 5, 1998, Pages 522-527

  Sloand, James A ^a,b   Shelly, Mark A ^a   Erenstone, Anne L ^a   Schiff, Melissa J ^a   Talley, Thomas E ^a   Dhakal, Madhavendra P ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Highland Hospital Rochester   (United States)

Author keywords

Erythropoiesis; Erythropoietin; Ferritin levels; Iron dextran

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; FERRITIN; IRON DEXTRAN;

ABDOMINAL CRAMP; ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ENZYME BLOOD LEVEL; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEMODIALYSIS; HOME DIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY; KIDNEY FAILURE; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

EID: 0031772668     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089801800511     Document Type: Article

References (19)

1. Donnelly SM, Posen GA, Ali MA. Oral iron absorption in hemodialysis patients treated with erythropoietin. Clin Invest Med 1991; 14:271-6.
2. Hamstra RD, Block MH, Schocket AL. Intravenous iron dextran in clinical medicine. JAMA 1980; 243(17): 1726-31.
3. Macdougall IC, Tacker JT, Tomson CRV, Baker LRI, Raine AEG. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 1996; 50:1694-9.
4. NKF Dialysis Outcomes Quality Initiative Work Group. NKF-Dialysis Outcomes Quality Initiative clinical practice guidelines for the treatment of anemia of chronic renal failure: iron support. Am J Kidney Dis 1997; 30(Suppl 3):S202-12.
5. Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, Ballard H. Clinical use of the total dose intravenous infusion of iron dextran. J Lab Clin Med 1988; 111(5):566-70.
6. Jacobs P, Wood L. Clinical use of total dose infusion of iron dextran. S Afr Med J 1985; 67:837-8.
7. Kumpf VJ, Holland EG. Parenteral iron dextran therapy. DICP, Ann Pharmacother 1990; 24:162-6.
8. Ahsan N, Groff JA, Waybill MA. Efficacy of bolus intravenous iron dextran treatment in peritoneal dialysis patients receiving recombinant human erythropoietin. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1996; 12:161-6.
9. Hanson DB, Hendeles L. Guide to total dose intravenous iron dextran. Am J Hosp Pharm 1974; 31:592-5.
10. Lowrie EG, Ling J, Lew NL, Yiu Y. The relative contribution of measured variables to death risk among hemodialysis patients. In: Friedman EA, ed. Death on hemodialysis: preventable or inevitable? 13. Boston, MA: Kluwer Academic, 1994:121-41.
11. Tarng DC, Chen TW, Huang TP. Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients. Am J Nephrol 1995; 15:230-7.
12. Fishbane S, Maesaka JK. Iron management in end stage renal disease. Am J Kidney Dis 1997; 29:319-33.
13. Fleming LW, Hopwood D, Shepherd AN, Stewart WK. Hepatic iron in dialyzed patients given intravenous iron dextran. J Clin Pathol 1990; 43:119-24.
14. Kleiner MJ, Van Wyck DB, Kaupke CJ, Kirlin LF. The role of iron and other factors in patients unresponsive to erythropoietin therapy. Semin Dial 1995; 8:29-34.
15. Van Wyck DB, Stivelman JC, Ruiz J, Kirlin LF, Katz MA, Ogden DA. Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int 1989; 35:712-16.
16. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86:803-11.
17. Weinberg ED. Iron withholdings: a defense against infection and neoplasia. Physiol Rev 1984; 64:65-102.
18. Collins J, Ebben J, Ma J. Frequent IV iron dosing is associated with higher infectious deaths. J Am Soc Nephrol 1997; 8:190.
19. Auerbach M, Winchester J, Wahab A, Richards K, McKinley M, Hall F, et al. A randomized trial of three iron dextran infusion methods for anemia in erythropoietin-treated dialysis patients. Am J Kidney Dis 1998; 31:81-6.